The company incurred higher R&D costs over its latest quarter but cancer biopharm company Zymew... Read More
With cash on hand to fund the business through 2022, Zymeworks (Zymeworks Stock Quote, Chart, News N... Read More
Zymeworks (Zymeworks Stock Quote, Chart, News NYSE:ZYME) has what investors should be looking for in... Read More
Paradigm Capital analyst Scott McAuley is expecting big things from clinical stage company Zymeworks... Read More
Clinical-stage biopharmaceutical company Zymeworks (Zymeworks Stock Quote, Chart TSX, NYSE:ZYME) has... Read More
Paradigm Capital analyst Rahul Sarugaser is expecting 2019 to be a big clinical year for Zymeworks (... Read More